-The Times of India NEW DELHI: Alzheimer's disease, which is the cause of dementia in a large number of people, can be a very difficult journey not only for the patient but also for the caregiver. Shivani Roy's grandfather, who suffered Alzheimer's for over a decade, left his house in January 2001 never to return. The family tried its best but couldn't locate him. Getting lost in the city is a common...
More »SEARCH RESULT
Total Matching Records found : 1504
Spectre of drug shortage over TB treatment -Rupali Mukherjee
-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for...
More »Prices of key drugs to be cut by up to half-Sushmi Dey
-The Business Standard NPPA to soon notify prices in line with new pharma pricing policy Some key cancer drugs, antibiotics and Medicines to treat cardiovascular diseases and tuberculosis are set to become cheaper by up to 50 per cent within the next 45 days. The National Pharmaceutical Pricing Authority (NPPA) will soon notify prices of as many as 150 packs of essential Medicines in line with the new pharma pricing policy, according...
More »Food security: How the states feed India
-The Indian Express Trendsetters & tweakers Act one Chhattisgarh already has a food security law in place. It became last December the first state to pass a food security bill, which covers several sections not under existing schemes. The Act makes food entitlement a right and depriving anyone of that an offence. If PDS grains, for instance, are being diverted, the officials involved will face penal provisions. The Act also seeks to empower women...
More »Govt bans common painkiller
-The Telegraph The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage. The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all Medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans...
More »
